Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

We were surprised to see that a story that covered as much ground as this one did somehow missed costs. The competing story by NBC spelled out the costs. The story nicely explained that while one of the new studies showed, as expected, that following the updated statin guidelines did increase the number of people who would be treated with statins, following the guidelines would apparently not have saved a significant number of people from dying or having a heart attack or stroke. The story said, “Among the people eligible for statins under the old guidelines, 6.9 percent had a heart attack or stroke or died from coronary disease over the ensuing nine years. Among those eligible for statins under the new guidelines, the figure was 6.3 percent, almost as high. That suggests that the new guidelines do not lead to treatment of many more people who do not need statins.” At the same time, the story noted that the new guidelines “over all did a better job in discriminating between those who should and should not get statins.” It said that “only 1 percent of participants deemed ineligible for statins under the new guidelines had a heart attack or stroke over nine years, compared with 2.4 percent of those ineligible under the old guidelines.” While an NBC story also used absolute numbers in talking about the potential benefits in terms of heart attacks, we liked the greater level of context provided in the Times piece. Nevertheless, we think it would have been useful for the Times to include the Number Needed to Treat in its discussion of benefits —  this is an easy-to-understand metric that was reported in the study. In addition, we question the Times’s contention that the new criteria “do not lead to treatment of many more people who do not need statins.” According to the study, approximately 94% of both guideline groups did not have a cardiovascular event, and yet the new criteria now extend the use of statins to much larger number of people. In light of such findings, it’s unclear that the new criteria don’t lead to unnecessary treatment for more people as the Time states. We wish the story had explored this result more thoroughly. We thought that NBC did a better job detailing some of the potential harms from statin use, but we give the Times credit here for framing the story as a discussion of risks vs. benefits and making it clear that experts critical of the new guidelines believe that they “would lead millions of additional people to take statins, exposing them to potential side effects such as muscle pain or damage with little to gain.” Covering two studies in little more than 1,000 words is already a feat. Doing so while bringing in enough context to explain the caveats to the study is an order of magnitude greater. Compared to the NBC piece, the Times did a superior job showing that, despite the enthusiasm in some quarters of the scientific community, the two studies did not settle the debate over whether statins should be more widely prescribed. The story did not engage in disease mongering. The story sought out and made good use of independent sources. It mentions that the guidelines were widely criticized and links to some printed criticisms made at the time. It quotes a variety of supportive and critical researchers regarding their opinions on the new research. The story did not make any reference to dietary changes, lifestyle changes, or exercise. The story made it clear that statins are widely prescribed. One in four Americans take them by some estimates. The story established that the findings of the studies were not novel but rather were in keeping with earlier findings about statins. Because it contains comments from independent experts, we can be sure the story did not rely excessively on any news release.
2 Studies Back Guidelines for Wider Use of Statins

Modi, who imposed a three-week long nationwide lockdown on March 25, asked all citizens to turn out their lights for nine minutes at 9 p.m. local time on Sunday, and to display lamps and candles in a show of solidarity. Modi’s call was met with a huge response, with many people lighting up their balconies. Others lit firecrackers, played musical instruments, and sang patriotic songs. Grid data showed India’s national power consumption plunging more than a quarter in a matter of minutes. The show of unity came as the total number of coronavirus cases in India increased to 3,577, while the death toll rose to 83. Some officials have warned that lockdowns could continue beyond April 14 in parts of India where new cases have been detected. With the number of cases continuing to increase daily, India restricted the export of most diagnostic testing kits. The government, which in recent weeks already banned the export of certain medicines, along with ventilators, masks and other protective gear needed by both patients and medical staff, issued the latest directive late on Saturday. The move came even as U.S. President Donald Trump urged Modi in a phone call to release supplies of anti-malaria drug hydroxychloroquine, which is being tested as a possible treatment for patients with COVID-19, the disease caused by the novel coronavirus. “The two leaders agreed to remain in touch on the issue of global supply chains for critical pharmaceuticals and medical supplies and to ensure they continue to function as smoothly as possible during the global health crisis,” White House spokesman Judd Deere said on Saturday. In a briefing note on the conversation, India said the two leaders “agreed to deploy the full strength of the India–U.S. partnership to resolutely and effectively combat COVID-19.”  The total number of confirmed COVID-19 cases in South Asia, home to roughly 1.9 billion people, topped 7,000 on Sunday, even as the death toll from the respiratory disease rose to 149 in the region. While the figures are relatively low in comparison with the United States, China, Italy and Spain, health experts fear that the spread of the pandemic in South Asia could overwhelm already weak public health systems in the region. Bangladesh’s Prime Minister Sheikh Hasina on Sunday unveiled a 727.50 billion taka ($8.56 billion) stimulus package to help the economy weather the impact of the coronavirus outbreak. “The amount is equivalent to 2.52 percent of gross domestic product,” Hasina said in a televised address. Reuters reported earlier this month that Bangladesh, the world’s second-largest apparel producer after China, was set to lose roughly $6 billion in export revenue this financial year amid order cancellations from some of the world’s largest brands and retailers. Bangladesh has recorded 88 cases of the disease, with nine deaths. Following are government figures on the spread of the coronavirus in South Asia:  * India has 3,577 cases, including 83 deaths  * Pakistan has 3,059 cases, including 45 deaths  * Afghanistan has 349 cases, including 7 deaths  * Sri Lanka has 175 cases, including 5 deaths  * Bangladesh has 88 cases, including 9 deaths  * Maldives has 19 cases and no deaths  * Nepal has nine cases and no deaths  * Bhutan has five cases and no deaths
Indians light lamps to heed Modi's call for coronavirus comradeship.

Hendrick Motorsports announced Earnhardt’s status Wednesday. Earnhardt was evaluated by doctors at the University of Pittsburgh Medical Center Sports Medicine Concussion Program. Owner Rick Hendrick said Earnhardt is working hard to get back and will follow doctors’ recommendations for his recovery. Hendrick said the program is fully behind Earnhardt. Alex Bowman, who drove for Earnhardt at New Hampshire, will return to drive the No. 88 Chevrolet at Michigan this weekend. Jeff Gordon will fill in at Darlington, where he has won seven races. Gordon has driven the past four races for Earnhardt.

Dale Earnhardt Jr. to miss at least 2 more races.